Patents by Inventor Teruo Miyata
Teruo Miyata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 4704131Abstract: The medical material contains heparinized collagen in which heparin has been bonded to protamine covalently fixed on collagen, and, owing to its excellent compatibility with living bodies, especially, its superb antithrombotic property, can be suitably used as a substituent material for tissues or organs which are brought into direct contact with blood, namely, as aritificial vessels, artificial valves and patching materials for cardiovascular organs, and the above medical material is also suitable as a membrane having anti-adhesion effects. The medical material is obtained by immersing and treating a natural or artificial material successively in an aqueous protamine solution, an aqueous glutaraldehyde solution and an aqueous heparin solution.Type: GrantFiled: October 15, 1984Date of Patent: November 3, 1987Assignee: Koken Co., Ltd.Inventors: Yasuharu Noishiki, Teruo Miyata
-
Patent number: 4695281Abstract: The medical material according to this invention contains collagen, which as been chemically modified by saccinylation of thermal --NH.sub.2 groups of said chains attached to poly peptide chains of the collagen so that the --NH.sub.2 groups are converted into groups having --COOH groups. This succinylation can be carried out by reacting succinic anhydride with the --NH.sub.2 groups of the collagen. Since the above medical material has excellent compatibility with living bodies, especially, with blood, it is suitable to use it as a replacement material for tissues and/or organs which are kept in contact with blood at their surfaces, namely, is suitable for use in artificial blood vessels, artificial valves, some parts of artificial hearts which are kept in contact with blood at said parts, etc. and as a patching material for hearts.Type: GrantFiled: March 25, 1983Date of Patent: September 22, 1987Assignee: Koken Co., Ltd.Inventors: Teruo Miyata, Yasuharu Noishiki
-
Patent number: 4690973Abstract: This invention concerns a production process of an antithrombogenic and antiadhesive material which can favorably be used as artificial blood vessels, artificial valves, grafting patches for cardiovascular organs, artificial heart catheters and so on. The gist of this invention is constructed substantially of subjecting glycidyltrialkylammonium halide such as glycidyltrimethylammonium chloride to the reaction with a material comprising pure collagen or collagen and other components like mucopolysaccharide in order to introduce a cationic quaternary functional group in collagen molecules of the material and then subjecting heparin to the ionic combination with the cationic functional group introduced.Type: GrantFiled: July 15, 1986Date of Patent: September 1, 1987Assignee: Koken Company LimitedInventors: Yasuharu Noishiki, Kazuhiko Kodaira, Masayasu Furuse, Teruo Miyata, Takeaki Miyamoto, Hiraku Ito
-
Patent number: 4687518Abstract: Pyrogen-free collagen useful for manufacturing soft contact lenses is made by performing all manufacturing process steps under aseptic conditions.Type: GrantFiled: November 6, 1985Date of Patent: August 18, 1987Assignee: Optical Corp.Inventors: Teruo Miyata, Albert L. Rubin
-
Patent number: 4642118Abstract: This invention concerns a double-layered man-made skin which is prepared by laminating a collagen sponge sheet and a poly-.alpha.-amino acid membrane that has a good affinity with tissue cells and an appropriate permeability for moisture. When the man-made skin is applied on burns, cuts or wounds, the fibroblasts proliferate in the collagen sponge sheet forming a three-dimensional structure, while the epidermal cells proliferate in the region between the poly-.alpha.-amino acid membrane and a collagen sponge sheet. The poly-.alpha.-amino acid membrane plays a role in protecting affected part and in providing an optimum condition for the proliferation of fibroblasts and epidermal cells, and then it falls off as the epidermis completely regenerates. On the other hand, the collagen sponge sheet assimilates in the living tissue after having played a general role of the dermis.Type: GrantFiled: June 6, 1985Date of Patent: February 10, 1987Assignee: Koken Co., Ltd.Inventors: Yoshimitsu Kuroyanagi, Teruo Miyata, Manabu Seno
-
Patent number: 4592864Abstract: An aqueous atelocollagen solution, which can be injected into living bodies as a medical material, has a pH value in the range from about 6.5 to about 8.0 and an osmolality in the range from about 250 to about 320 mOsm/KgH.sub.2 O, and contains a phosphate buffer solution, or glucose and a phosphate buffer solution, as an agent to adjust pH and osmolality within the ranges specified above. This aqueous atelocollagen solution can be prepared by dissolving atelocollagen in an aqueous acidic solution and adding the above-mentioned pH- and osmolality-adjusting agent to the resulting solution in such an amount as to adjust pH and osmolality of the final solution within the ranges mentioned above.Type: GrantFiled: July 25, 1984Date of Patent: June 3, 1986Assignee: Koken Co., Ltd.Inventors: Teruo Miyata, Toshio Taira
-
Patent number: 4565580Abstract: A substrate consisting essentially of regenerated collagen fibrils is provided which is in the form of a bead, or microsphere and comprises irregularly entangled regenerated collagen fibrils each having a diameter of 10-1000 m.mu. and an aqueous solution existing between the regenerated collagen fibrils, the content of the regenerated collagen fibrils being 20-0.01 wt. %. The substrate can be used for cell culture or for measuring adhesion activity of blood platelet.According to one method of manufacturing the collagen beads, an acidic aqueous collagen solution is dispersed in a water-immiscible organic solvent in the form of numerous droplets to form an emulsion, and the droplets are then coagulated by addition of a water-miscible organic solvent and an alkali to the emulsion.Type: GrantFiled: March 7, 1984Date of Patent: January 21, 1986Assignee: Koken Co., Ltd.Inventors: Teruo Miyata, Shinichi Namiki
-
Patent number: 4559304Abstract: A substratum for cell culture which comprises a chemically modified collagen rich in either positive or negative charges when under culture conditions. The substratum is prepared by modifying the amino groups or carboxyl groups of collagen. The chemically modified collagen enhances the adherence and proliferation of animal cells much more actively than unmodified collagen in the presence or absence of bovine fetus serum. The cultured animal cells can be detached efficiently from the chemically modified collagen. This allows for highly selective isolation and recovery of the cultured animal cells which can be accomplished without incurring any injury from the chemically modified collagen.Type: GrantFiled: August 8, 1983Date of Patent: December 17, 1985Assignee: Koken Co., Ltd.Inventors: Shunji Kasai, Toshihiro Akaike, Teruo Miyata
-
Patent number: 4406853Abstract: A novel collagen condom consists of isotropically-strong, crosslinked, regenerated fiber collagen. A method of preparation involves the steps of at least twice dipping a mandrel into an acidic collagen dispersion; slowly removing the mandrel under spinning conditions; neutralizing and drying the membrane between dippings; crosslinking the finally dried membrane while on the mandrel and removing the membrane from the mandrel.Type: GrantFiled: September 15, 1981Date of Patent: September 27, 1983Assignee: Collagen Development CorporationInventor: Teruo Miyata
-
Patent number: 4349026Abstract: A novel collagen condom consists of isotropically-strong, crosslinked, regenerated fiber collagen. A method of preparation involves the steps of at least twice dipping a mandrel into an acidic collagen dispersion; slowly removing the mandrel under spinning conditions; neutralizing and drying the membrane between dippings; crosslinking the finally dried membrane while on the mandrel and removing the membrane from the mandrel.Type: GrantFiled: February 28, 1980Date of Patent: September 14, 1982Assignee: Collagen Development Corp.Inventor: Teruo Miyata
-
Patent number: 4314380Abstract: Artificial bone is prepared from animal bone treated for removal of organics, burned, baked and immersed in atelocollagen solution.Type: GrantFiled: September 26, 1980Date of Patent: February 9, 1982Assignee: Koken Co., Ltd.Inventors: Teruo Miyata, Taichiro Akiyama, Masayasu Furuse
-
Patent number: 4294241Abstract: Skin or wound dressings are prepared in gel or sheet form from enzyme-solubilized collagen and/or such chemically modified collagen. Improved sheet form dressing is prepared by tubular extrusion of such collagen gels.Type: GrantFiled: October 19, 1979Date of Patent: October 13, 1981Inventor: Teruo Miyata
-
Patent number: 4271070Abstract: Chemically-modified quaternary-structured fiber collagens of minimum molecular length, diameter and periodicity, and containing a relatively high positive electrostatic charge are claimed as hemostatic agents. Specific examples are guanidinated, esterified, and guanidinated-esterified collagen fibers of the type described.Type: GrantFiled: May 5, 1980Date of Patent: June 2, 1981Assignee: Cornell Research Foundation, Inc.Inventors: Teruo Miyata, Albert L. Rubin, Kurt H. Stenzel
-
Patent number: 4268131Abstract: Soft contact lenses are made from purified fiber collagen and mixtures of such fiber with purified solubilized collagen.Type: GrantFiled: April 11, 1979Date of Patent: May 19, 1981Assignee: Opticol CorporationInventors: Teruo Miyata, Albert L. Rubin, Kurt H. Stenzel, Michael W. Dunn
-
Patent number: 4264155Abstract: Improved soft contact lenses are made from collagen gels to which water-soluble organic polyhydroxy polymers are added, e.g. mucopolysaccharides, polyvinyl alcohols, etc.Type: GrantFiled: July 9, 1979Date of Patent: April 28, 1981Assignee: Opticol CorporationInventor: Teruo Miyata
-
Patent number: 4260228Abstract: An improved collagen gel soft contact lens is prepared from an aldehyde-crosslinked, lens-shaped collagen gel containing a water-soluble, aliphatic, monomeric, polyhydroxy compound, e.g., glucose.Type: GrantFiled: January 21, 1980Date of Patent: April 7, 1981Assignee: Opticol CorporationInventor: Teruo Miyata
-
Patent number: 4223984Abstract: Soft contact lenses are made from solubilized, defatted, transparent, cross-linked collagen, and/or chemically-modified collagen.Type: GrantFiled: April 4, 1979Date of Patent: September 23, 1980Assignee: Opticol CorporationInventors: Teruo Miyata, Albert L. Rubin, Michael W. Dunn, Kurt H. Stenzel
-
Patent number: 4215200Abstract: Polymers of quaternary-structured collagen of minimum length, diameter and periodicity, and containing a relatively high positive electrostatic charge are claimed as hemostatic agents. Specific examples are guanidnated polymers of the type described, esterified polymers, and esterified-guanidinated polymers.Type: GrantFiled: October 2, 1978Date of Patent: July 29, 1980Assignee: Cornell Research Foundation, Inc.Inventors: Teruo Miyata, Kurt H. Stenzel, Albert L. Rubin
-
Patent number: 4164559Abstract: Chemically-modified collagen membrane prepared at physiologic pH and soluble thereat provides a carrier for ophthalmic medication leaving no removable material after drug release.Type: GrantFiled: September 21, 1977Date of Patent: August 14, 1979Assignee: Cornell Research Foundation, Inc.Inventors: Teruo Miyata, Albert L. Rubin, Kurt H. Stenzel, Michael W. Dunn